21-42850075-G-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_018669.6(WDR4):​c.1213C>A​(p.Pro405Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P405L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)

Consequence

WDR4
NM_018669.6 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.766

Publications

0 publications found
Variant links:
Genes affected
WDR4 (HGNC:12756): (WD repeat domain 4) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is excluded as a candidate for a form of nonsyndromic deafness (DFNB10), but is still a candidate for other disorders mapped to 21q22.3 as well as for the development of Down syndrome phenotypes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012]
WDR4 Gene-Disease associations (from GenCC):
  • microcephaly, growth deficiency, seizures, and brain malformations
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Galloway-Mowat syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Galloway-Mowat syndrome 6
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.02395615).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR4NM_018669.6 linkc.1213C>A p.Pro405Thr missense_variant Exon 11 of 11 ENST00000398208.3 NP_061139.2 P57081-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR4ENST00000398208.3 linkc.1213C>A p.Pro405Thr missense_variant Exon 11 of 11 1 NM_018669.6 ENSP00000381266.2 P57081-1
WDR4ENST00000330317.6 linkc.1213C>A p.Pro405Thr missense_variant Exon 11 of 12 1 ENSP00000328671.2 P57081-1
WDR4ENST00000476326.5 linkn.1128C>A non_coding_transcript_exon_variant Exon 11 of 11 1
WDR4ENST00000492742.5 linkn.1356C>A non_coding_transcript_exon_variant Exon 11 of 11 2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251232
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Feb 27, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1213C>A (p.P405T) alteration is located in exon 11 (coding exon 11) of the WDR4 gene. This alteration results from a C to A substitution at nucleotide position 1213, causing the proline (P) at amino acid position 405 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.026
DANN
Benign
0.31
DEOGEN2
Benign
0.013
T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.45
.;T
M_CAP
Benign
0.063
D
MetaRNN
Benign
0.024
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
-0.77
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.040
N;N
REVEL
Benign
0.23
Sift
Benign
0.60
T;T
Sift4G
Benign
0.68
T;T
Polyphen
0.0
B;B
Vest4
0.10
MutPred
0.088
Gain of MoRF binding (P = 0.0394);Gain of MoRF binding (P = 0.0394);
MVP
0.072
MPC
0.023
ClinPred
0.049
T
GERP RS
-7.2
Varity_R
0.044
gMVP
0.24
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759520884; hg19: chr21-44270185; API